NCT05171166 2025-12-18
Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial.
Peking University
Phase 2/3 Terminated
Peking University
National Cancer Institute (NCI)
Assistance Publique - Hôpitaux de Paris
Rigshospitalet, Denmark